• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

4

CATEGORIES

  • 5
  • 4
  • 4
  • 1
  • 1
  • 1

PRICE

8
8
9
13

PUBLISHED

2
5
8
13

PRODUCT TYPE

7
6

Search "Genmab A/S - Strategy and SWOT Report" returned 13 results.

PRODUCT TITLE

Genmab A/S - SWOT, Strategy and Corporate Finance Report

Genmab A/S - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and...

January 2013
FROM

Genmab A/S - Strategy and SWOT Report

Genmab A/S - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and...

January 2015
FROM

NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review

NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

May 2014
FROM

ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review

ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The...

March 2015
FROM

Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market

Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market Summary GBI Research's report, “Upstream Processing in Biopharmaceuticals...

March 2011
FROM

PDL BioPharma, Inc. (PDLI) - Financial and Strategic SWOT Analysis Review

PDL BioPharma, Inc. (PDLI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by...

April 2015
FROM

BioInvent International AB (BINV) - Financial and Strategic SWOT Analysis Review

BioInvent International AB (BINV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2015
FROM
H Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review H Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

H Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review

H Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review Summary H Lundbeck A/S (Lundbeck) is a pharmaceutical company, engaged in the research, development, manufacturing and marketing...

April 2011
FROM

Seattle Genetics, Inc. (SGEN) - Financial and Strategic SWOT Analysis Review

Seattle Genetics, Inc. (SGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

March 2015
FROM
Cancer Therapeutics 2006: Market Dynamics and R&D Trends Cancer Therapeutics 2006: Market Dynamics and R&D Trends - Product Thumbnail Image

Cancer Therapeutics 2006: Market Dynamics and R&D Trends

Together, the four major cancer markets, which include colorectal, prostate, lung and breast cancer were valued at well over $16 billion in 2005, which was an increase of 14 percent in value since 2004....

December 2005
FROM

Global Rheumatoid Arthritis Drugs Market 2014-2018

About Rheumatoid Arthritis RA is a chronic disease that leads to inflammation and pain in the human body's joints such as wrists, fingers, knees, feet, and ankles. In addition, it causes inflammation...

July 2014
FROM

Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024

Antibody drug conjugates (ADCs) are a new class of therapeutic agents, gaining increasing attention from both large and small pharmaceutical companies. Generally addressed as the marriage of an antibody...

August 2014
FROM

Biopharmaceutical Contract Manufacturing Market, 2015 - 2025

Characterized by a rapidly expanding product pipeline and a capital intensive manufacturing business, the biopharmaceutical market is witnessing a growing trend towards contract manufacturing. In addition...

May 2015
FROM
Loading Indicator

Our Clients

Amneal Pharmaceuticals LLC. Amgen Inc. LEO Laboratories Ltd. Pfizer, Inc. Roche Diagnostics Ltd. Merck & Co., Inc. Sanofi S.A.